X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA J.B.CHEMICALS PLETHICO PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x -1.1 15.1 - View Chart
P/BV x 0.0 2.4 0.7% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 PLETHICO PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
J.B.CHEMICALS
Mar-16
PLETHICO PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs395318 124.1%   
Low Rs31200 15.7%   
Sales per share (Unadj.) Rs604.4148.0 408.4%  
Earnings per share (Unadj.) Rs32.519.1 170.2%  
Cash flow per share (Unadj.) Rs51.323.9 214.3%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs473.6128.9 367.2%  
Shares outstanding (eoy) m34.0884.82 40.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.41.7 20.2%   
Avg P/E ratio x6.613.6 48.4%  
P/CF ratio (eoy) x4.210.8 38.4%  
Price / Book Value ratio x0.52.0 22.4%  
Dividend payout %02.6 0.0%   
Avg Mkt Cap Rs m7,26221,951 33.1%   
No. of employees `000NA2.7 0.0%   
Total wages/salary Rs m1,5961,841 86.7%   
Avg. sales/employee Rs ThNM4,590.9-  
Avg. wages/employee Rs ThNM673.4-  
Avg. net profit/employee Rs ThNM592.1-  
INCOME DATA
Net Sales Rs m20,59812,551 164.1%  
Other income Rs m386542 71.3%   
Total revenues Rs m20,98413,093 160.3%   
Gross profit Rs m2,8182,055 137.1%  
Depreciation Rs m642412 155.7%   
Interest Rs m1,59396 1,664.8%   
Profit before tax Rs m9692,088 46.4%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138469 -29.5%   
Profit after tax Rs m1,1071,619 68.4%  
Gross profit margin %13.716.4 83.6%  
Effective tax rate %-14.322.5 -63.6%   
Net profit margin %5.412.9 41.7%  
BALANCE SHEET DATA
Current assets Rs m18,8777,778 242.7%   
Current liabilities Rs m11,8964,358 273.0%   
Net working cap to sales %33.927.2 124.4%  
Current ratio x1.61.8 88.9%  
Inventory Days Days3655 65.7%  
Debtors Days Days19880 247.2%  
Net fixed assets Rs m9,8615,713 172.6%   
Share capital Rs m341170 200.9%   
"Free" reserves Rs m12,33110,547 116.9%   
Net worth Rs m16,13910,937 147.6%   
Long term debt Rs m4,7060-   
Total assets Rs m33,14615,574 212.8%  
Interest coverage x1.622.8 7.0%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60.8 77.1%   
Return on assets %8.111.0 74.0%  
Return on equity %6.914.8 46.3%  
Return on capital %12.320.0 61.6%  
Exports to sales %21.448.7 43.9%   
Imports to sales %15.27.1 215.0%   
Exports (fob) Rs m4,4026,115 72.0%   
Imports (cif) Rs m3,136889 352.9%   
Fx inflow Rs m4,4026,169 71.4%   
Fx outflow Rs m3,1841,285 247.8%   
Net fx Rs m1,2194,884 24.9%   
CASH FLOW
From Operations Rs m2,4371,397 174.5%  
From Investments Rs m-6,265-320 1,955.9%  
From Financial Activity Rs m2,490-1,196 -208.2%  
Net Cashflow Rs m-1,337-102 1,307.1%  

Share Holding

Indian Promoters % 82.7 55.4 149.3%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 4.3 3.4 126.8%  
FIIs % 5.5 3.9 141.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 37.0 20.3%  
Shareholders   10,665 30,437 35.0%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   ALEMBIC LTD  AUROBINDO PHARMA  IPCA LABS  GLENMARK PHARMA  SUN PHARMA  

Compare PLETHICO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 5-YR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS